Please enable Javascript to use all features and improve your user experience.
EHC 2023
Programme
People
Search
DE
Back
ePoster
LP002
Exposure, safety and effectiveness of 75 mg rimegepant administered as needed in the acute treatment of migraine among chinese adults: Interim analysis of a long-term safety study
Shengyuan Yu
Beijing, CN
Appointment
Date:
06/12/2023
Time:
21:00
–
21:05
Talk time:
3 Min.
Discussion time:
2 Min.
Location / Stream:
Industry hall
Poster
Exposure, safety and effectiveness of 75 mg rimegepant administered as needed in the acute treatment of migraine among chinese adults: Interim analysis of a long-term safety study
Session
ePoster 01
Topic
New developments in prophylactic medications and acute medications
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy